Holen Sie sich die Stockscreener-App
2.22
0.91%
0.02
Handel nachbörslich:
2.23
0.010
+0.45%
Schlusskurs vom Vortag:
$2.20
Offen:
$2.19
24-Stunden-Volumen:
101.24K
Relative Volume:
1.39
Marktkapitalisierung:
$91.03M
Einnahmen:
$2.70M
Nettoeinkommen (Verlust:
$5.53M
KGV:
20.18
EPS:
0.11
Netto-Cashflow:
$-10.55M
1W Leistung:
+0.91%
1M Leistung:
+6.22%
6M Leistung:
+3.74%
1J Leistung:
-6.72%
1-Tages-Spanne:
$2.1895
$2.26
1-Wochen-Bereich:
$2.13
$2.26
52-Wochen-Spanne:
$1.82
$3.09
Oramed Pharmaceuticals Inc Stock (ORMP) Company Profile
Firmenname
Oramed Pharmaceuticals Inc
Sektor
Branche
Telefon
646-844-1164
Adresse
1185 AVENUE OF THE AMERICAS, 3RD FLOOR, NEW YORK, NY
Vergleichen Sie ORMP mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ORMP
Oramed Pharmaceuticals Inc
|
2.22 | 88.16M | 2.70M | 5.53M | -10.55M | 0.11 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Oramed Pharmaceuticals Inc Stock (ORMP) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-01-12 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2022-02-18 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2021-04-20 | Eingeleitet | Canaccord Genuity | Buy |
| 2021-02-09 | Eingeleitet | National Securities | Buy |
| 2020-12-03 | Eingeleitet | Alliance Global Partners | Buy |
| 2020-03-11 | Eingeleitet | Aegis Capital | Buy |
| 2019-09-11 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2017-12-11 | Fortgesetzt | B. Riley FBR, Inc. | Buy |
| 2016-05-26 | Bestätigt | FBR Capital | Outperform |
| 2015-12-01 | Bestätigt | H.C. Wainwright | Buy |
| 2015-11-19 | Eingeleitet | FBR Capital | Outperform |
| 2015-04-13 | Fortgesetzt | MLV & Co | Buy |
| 2014-01-30 | Bestätigt | Aegis Capital | Buy |
| 2014-01-08 | Bestätigt | Aegis Capital | Buy |
| 2014-01-08 | Eingeleitet | MLV & Co | Buy |
| 2013-12-03 | Eingeleitet | Aegis Capital | Buy |
Alle ansehen
Oramed Pharmaceuticals Inc Aktie (ORMP) Neueste Nachrichten
How cyclical is Oramed Pharmaceuticals Inc.’s revenue streamWeekly Loss Report & Stock Portfolio Risk Management - khodrobank.com
Statistical indicators supporting Oramed Pharmaceuticals Inc.’s strength2025 Price Action Summary & Free Real-Time Volume Trigger Notifications - Newser
Can Oramed Pharmaceuticals Inc. recover in the next quarterJuly 2025 Macro Moves & Entry and Exit Point Strategies - Newser
Published on: 2025-09-04 00:33:56 - Newser
What MACD and RSI say about Oramed Pharmaceuticals Inc.Weekly Trade Report & Weekly Breakout Opportunity Watchlist - Newser
Is a relief rally coming for Oramed Pharmaceuticals Inc. holdersTake Profit & Daily Growth Stock Investment Tips - Newser
How to use Fibonacci retracement on Oramed Pharmaceuticals Inc.2025 Big Picture & Technical Entry and Exit Alerts - Newser
Is this a good reentry point in Oramed Pharmaceuticals Inc.Market Rally & Risk Managed Investment Strategies - Newser
Intraday pattern recognizer results for Oramed Pharmaceuticals Inc.2025 Biggest Moves & Fast Moving Market Watchlists - Newser
Evaluating Oramed Pharmaceuticals Inc. with trendline analysis2025 Price Action Summary & Breakout Confirmation Alerts - Newser
Will Oramed Pharmaceuticals Inc. rebound enough to break evenPortfolio Risk Report & Real-Time Stock Entry Alerts - Newser
Historical volatility pattern of Oramed Pharmaceuticals Inc. visualizedEarnings Growth Summary & Free Community Supported Trade Ideas - Newser
Tick level data insight on Oramed Pharmaceuticals Inc. volatility - Newser
Is Oramed Pharmaceuticals Inc. still worth holding after the dipEarnings Risk Report & AI Enhanced Trading Alerts - Newser
Using Bollinger Bands to evaluate Oramed Pharmaceuticals Inc.Trade Analysis Summary & Safe Capital Allocation Plans - Newser
Is Oramed Pharmaceuticals Inc. a top pick in the sectorJuly 2025 Recap & Low Risk High Win Rate Picks - khodrobank.com
Can Oramed Pharmaceuticals Inc. sustain earnings growthEarnings Overview Report & Weekly Top Gainers Alerts - khodrobank.com
Sentiment analysis tools applied to Oramed Pharmaceuticals Inc.Weekly Trade Review & Accurate Intraday Trade Tips - Newser
Oramed Pharmaceuticals Inc. stock retracement – recovery analysisTrade Signal Summary & AI Forecasted Entry/Exit Points - Newser
What to do if you’re stuck in Oramed Pharmaceuticals Inc.Trade Volume Report & Smart Allocation Stock Reports - Newser
How sensitive is Oramed Pharmaceuticals Inc. to inflationJuly 2025 EndofMonth & Verified Entry Point Signals - khodrobank.com
Building trade automation scripts for Oramed Pharmaceuticals Inc.July 2025 Decliners & Real-Time Market Sentiment Alerts - Newser
Will Oramed Pharmaceuticals Inc. outperform during market ralliesTrade Exit Report & Free Low Drawdown Momentum Trade Ideas - khodrobank.com
Is Oramed Pharmaceuticals Inc. currently under institutional pressureWeekly Profit Analysis & Daily Profit Maximizing Tips - khodrobank.com
Does Oramed Pharmaceuticals Inc. stock reflect fundamentals2025 Earnings Impact & Real-Time Chart Pattern Alerts - خودرو بانک
Should you hold or exit Oramed Pharmaceuticals Inc. nowPortfolio Profit Report & Smart Allocation Stock Tips - Newser
What to do if you’re stuck in Oramed Pharmaceuticals IncTake Profit & Expert Curated Trade Setup Alerts - Newser
Chart based analysis of Oramed Pharmaceuticals Inc. trendsJuly 2025 Trade Ideas & Capital Efficient Trading Techniques - Newser
Can machine learning forecast Oramed Pharmaceuticals Inc. recovery2025 Earnings Impact & Weekly Market Pulse Updates - Newser
Can volume confirm reversal in Oramed Pharmaceuticals Inc.Weekly Trade Report & AI Powered Buy/Sell Recommendations - Newser
Will Volume Confirm Reversal in Oramed Pharmaceuticals Inc. getLinesFromResByArray error: size == 0 - newsyoung.net
Is this a good reentry point in Oramed Pharmaceuticals IncWeekly Profit Analysis & Stepwise Entry and Exit Trade Signals - Newser
Finanzdaten der Oramed Pharmaceuticals Inc-Aktie (ORMP)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.75%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):